Global Psychiatry Collaboration and Licensing Deals Directory, 2019-2024: Deal Trends, Leading Deals by Value, Most Active Dealmakers, Financials Terms, and More
26 avr. 2024 10h16 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
A Precision-Health Approach to Bipolar Disorder - A Free Webinar from the Brain & Behavior Research Foundation
06 sept. 2023 10h35 HE
|
Brain & Behavior Research Foundation
New York, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “A Precision-Health Approach to Bipolar Disorder” on Tuesday, September...
Global Precision Psychiatry Market Report to 2027 - Increasing Adoption of Inorganic Growth Strategies and Increased Demand for Genomics as Precision Psychiatry Drives Growth
23 mars 2023 05h08 HE
|
Research and Markets
Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Precision Psychiatry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Biomarkers (Genetic v/s Protein),...
Anticonvulsant Drugs Market to Surpass US$ 8,030.4 Million by 2030, Says Coherent Market Insights (CMI)
22 févr. 2023 09h15 HE
|
CMI
Burlingame, Feb. 22, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global anticonvulsant drugs market is estimated to be valued at US$ 6,757.8 in 2022 and is expected to...
Bipolar Disorder Treatment Market will achieve USD 5.7 billion by 2030 : GreyViews
30 janv. 2023 13h00 HE
|
GreyViews
Pune India, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
10 janv. 2023 10h15 HE
|
Silo Pharma, Inc.
Parkinson's disease, bipolar disorder, and chronic pain targeted in study Study aims to support psilocybin as a potential therapeutic for inflammatory disorders ENGLEWOOD CLIFFS,...
Behavioral Health Market to Cross Valuation of US$ 262 Bn by 2031; Growing Need for Treating Substance Abuse Disorders Underpins Abundant Avenues: TMR Study
06 juin 2022 12h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 06, 2022 (GLOBE NEWSWIRE) -- The global market study on behavioral health market is witnessing steady creation of lucrative opportunities on the back of...
Worldwide Bipolar Disorder Drugs and Treatment Industry to 2032 - by Drug Class and Region
03 juin 2022 06h18 HE
|
Research and Markets
Dublin, June 03, 2022 (GLOBE NEWSWIRE) -- The "Global Bipolar Disorder Drugs and Treatment Market 2022-2032" report has been added to ResearchAndMarkets.com's offering. A recent market study...
Global Mental Wellness Markets, 2022-2027 - Data Analytics Increasingly Powering Wellness / Use of Technology to Improve Outcomes / Growing Reign of Artificial Intelligence
11 mai 2022 06h48 HE
|
Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Mental Wellness Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global mental...
Bipolar Disorder Drugs and Treatment Market to Be Worth US$ 8.1 Billion by the Year 2032 - Comprehensive Research Report by FMI
22 mars 2022 10h00 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, March 22, 2022 (GLOBE NEWSWIRE) -- The global Bipolar Disorder Drugs And Treatment Market share, which was anticipated to be worth US$5.9 billion in 2022, is expected to...